Brain delivery of neurotoxin-I-loaded nanoparticles through intranasal administration

Yaoxue Xuebao

Volumn 43, Issue 4, 2008, Pages 431-434

  Cheng, Qiao Yuan ^a   Feng, Jian ^a   Li, Fan Zhu ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Brain delivery; Intranasal administration; Microdialysis; Nanoparticle; Neurotoxin I

Indexed keywords

COBROTOXIN; LACTIC ACID; NANOPARTICLE; NEUROTOXIN 1, NAJA NAJA OXIANA; NEUROTOXIN-1, NAJA NAJA OXIANA; POLYLACTIC ACID; POLYMER;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; INTRANASAL DRUG ADMINISTRATION; MALE; METABOLISM; MICRODIALYSIS; PARTICLE SIZE; PERIAQUEDUCTAL GRAY MATTER; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; AREA UNDER CURVE; COBRA NEUROTOXIN PROTEINS; DRUG DELIVERY SYSTEMS; LACTIC ACID; MALE; MICRODIALYSIS; NANOPARTICLES; PARTICLE SIZE; PERIAQUEDUCTAL GRAY; POLYMERS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 44649153756     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier [J]. Adv Drug Deliv Rev, 2001, 46:247-279.
2. Gloor SM, Wachtel M, Bolliger MF, et al. Molecular and cellular permeability control at the blood-brain barrier [J]. Brain Res Rev, 2001, 36:258-264.
3. Petri B, Bootz A, Khalansky A, et al. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butylcyanoacrylate) nanoparticles: revisiting the role of surfactants [J]. J Control Release, 2007, 117:51-58.
4. Illum L. Nasal drug delivery-possibilities, problems and solutions [J]. J Control Release, 2003, 87:187-198.
5. Pietrowsky R, Strüben C, Mölle M, et al. Brain potential changes after intranasal vs intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans [J]. Biol Psych, 1996, 39:332-340.
6. Denecke H, Czehak N, Pietrowsky R. Dose-response relationships of intranasal cholecystokinin and the P300 event-related brain potential [J]. Pharmacol Biochem Behav, 2002, 73:593-600.
7. Thorne RG, Pronk GJ, Padmanabhan V, et al. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration [J]. Neuroscience, 2004, 127: 481-496.
8. Kreuter J. Nanoparticulate systems for brain delivery of drugs [J]. Adv Drug Deliv Rev, 2001, 47:65-81.
9. Kreuter J, Alyautdin RN, Kharkevich DA, et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles ( nanoparticles) [J]. Brain Res, 1995, 674:171-174.
10. Paxinos G, Watson C. The rat brain in stereotaxic coordinates [M]. Sydney: Academic Press, 1997.
11. Zhang QZ, Zha LS, Zhang Y, et al. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats [J]. J Drug Target, 2006, 14:281-290.
12. Illum L. Transport of drugs from the nasal cavity to the central nervous system [J]. Eur J Pharm Sci, 2000, 11:1-18.
13. 125Icobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats [J]. Int J Pharm, 2007, 328:161-167.
14. Gao KP, Jiang XG. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J]. Int J Pharm, 2006, 310:213-219.
15. Kreuter J. Nanoparticulate systems for brain delivery of drugs [J]. Adv Drug Deliv Rev, 2001, 47:65-81.